Skip to main content
Back to Lux Capital

Lux Capital's Therapeutics Portfolio

Browse 5 Therapeutics companies funded by Lux Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
5
Total Funding in Therapeutics
$304.0M

Therapeutics Portfolio Companies (5)

Export
BiotechnologyHealth CareLife ScienceMedicalTherapeutics

H1 is on a mission to connect the world to the right doctor

New York, United States
May 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Cambridge, United States
March 2026
$40.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

Boulder, United States
September 2025
$150.0M
Series D

Founder Contacts

19,000+ verified contacts

Health CareMental HealthMobile AppsPersonal HealthTherapeutics

Daybreak Health specializes in providing online counseling services, especially for teens, helping to stabilize their mental fitness.

San Francisco, United States
August 2023
$13.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeuticsWellness

NILO Therapeutics is a biotechnology and therapeutics company.

New York, United States
October 2025
$101.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Lux Capital's Full Portfolio

View all companies funded by Lux Capital across every industry and funding stage.

View Full Lux Capital Portfolio